Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee-Reference-Cited by-同舟云学术

Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by an independent cause of death evaluation committee

Published:2016-06 Issue:1 Volume:115 Page:90-94
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Turner Emma L,Metcalfe Chris,Donovan Jenny L,Noble Sian,Sterne Jonathan A C,Lane J Athene,I Walsh Eleanor,Hill Elizabeth M,Down Liz,Ben-Shlomo Yoav,Oliver Steven E,Evans Simon,Brindle Peter,Williams Naomi J,Hughes Laura J,Davies Charlotte F,Ng Siaw Yein,Neal David E,Hamdy Freddie C,Albertsen Peter,Reid Colette M,Oxley Jon,McFarlane John,Robinson Mary C,Adolfsson Jan,Zietman Anthony,Baum Michael,Koupparis Anthony,Martin Richard M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2016162.pdf

Reference14 articles.

1. Albertsen PC, Walters S, Hanley JA (2000) A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995. J Urol 163: 519–523.

2. Barry MJ, Andriole GL, Culkin DJ, Fox SH, Jones KM, Carlyle MH, Wilt TJ (2013) Ascertaining cause of death among men in the prostate cancer intervention versus observation trial. Clin Trials 10: 907–914.

3. Black WC, Haggstrom DA, Welch HG (2002) All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst 94: 167–173.

4. Clopper CJ, Pearson ES (1934) The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 26: 404–413.

5. de Koning HJ, Blom J, Merkelbach JW, Raaijmakers R, Verhaegen H, Van VP, Nelen V, Coebergh JW, Hermans A, Ciatto S, Makinen T (2003) Determining the cause of death in randomized screening trial(s) for prostate cancer. BJU Int 92 (Suppl 2): 71–78.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality;JAMA;2024-05-07

2. Comparison of Vital Status, Cause of Death, and Follow-Up after Hematopoietic Cell Transplantation in Linked Center for International Blood and Marrow Transplant Research and California Cancer Registry Data, 1991 to 2018;Transplantation and Cellular Therapy;2024-02

3. Mortality from leading cancers in districts of England from 2002 to 2019: a population-based, spatiotemporal study;The Lancet Oncology;2024-01

4. Qualitative analysis of the coding of pathological data of cancer registry centers: A study in North of Iran;PLOS ONE;2023-09-15

5. Effect of Concomitant Medications on Treatment Response and Survival in De Novo Metastatic Prostate Cancer: Secondary Analysis of the LATITUDE Study;European Journal of Cancer;2023-09